Resources Sector

MEI Pharma Inc. – Developing therapies for cancer

February 26, 2018 scottb 0

Company: MEI Pharma Inc. Symbol: MEIP:US Length: 00:25:55 Presenter: Dr. Dan Gold, President & CEO Occasion: Richmond Club Lunch, Toronto MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel […]

High Technology Sector

Empire Industries – Building State of the Art Attractions

February 21, 2018 scottb 0

Company: Empire Industries Symbol: TSX-V: EIL Length: 00:24:11 Presenter: Guy Nelson, CEO Occasion: Richmond Club Lunch, Toronto Empire focuses on designing, supplying, and installing premium theme park, media-based attractions and ride systems for the global […]

Resources Sector

GrowMax Resources Corp. – Phosphate in Peru

October 5, 2017 scottb 0

Company: GrowMax Resources Corp. Symbol: GRO.V Length: 00:37:43 Presenter: Stephen Keith, President & CEO Occasion: Richmond Club Lunch, Toronto GrowMax Resources Corp. is a publicly listed Canadian company (Ticker GRO on TSX-V) focused on exploration and […]

Healthcare and Biotech Sector

Aphria – Developing the Medical Marijuana Business

April 20, 2017 scottb 0

Company: Aphria Inc Symbol: CVE: APH Length: 00:24:03 Presenter: Vic Neufeld, Chairman Occasion: Richmond Club Lunch, Toronto Aphria, a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in […]

Resources Sector

African Queen Mines – Mineral Properties in BC

February 22, 2017 scottb 0

Company: African Queen Mines Ltd. Symbol: AQ.V / QM0.F Length: 00:36:15 Presenter: Irwin Olian, Chairman, President & CEO Occasion: Richmond Club Lunch, Toronto African Queen Mines Ltd. and its subsidiaries acquire, explore and develop mineral […]

Healthcare and Biotech Sector

Oncolytics Biotech – Development of Oncolytic Viruses

October 26, 2016 scottb 0

Company: Oncolytics Biotech Inc. Symbol: TSX: ONC Length: 00:19:39 Presenter: Dr. Brad Thompson, Chairman, President & CEO Occasion: Richmond Club Lunch, Toronto Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use […]

1 2 3 4 5 6